MassMutual Private Wealth & Trust’s Cullinan Oncology CGEM Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$492	Hold	27	–	–	﹤0.01%	2273
2026 Q1	$384	Hold	27	–	–	﹤0.01%	2270
2025 Q4	$279	Hold	27	–	–	﹤0.01%	2303
2025 Q3	$160	Buy	+27	New	+$198	﹤0.01%	2330
2025 Q2	–	Sell	-36	Closed	-$273	–	2371
2025 Q1	$273	Hold	36	–	–	﹤0.01%	2281
2024 Q4	$438	Hold	36	–	–	﹤0.01%	2156
2024 Q3	$603	Hold	36	–	–	﹤0.01%	1952
2024 Q2	$628	Hold	36	–	–	﹤0.01%	1926
2024 Q1	$613	Hold	36	–	–	﹤0.01%	1820
2023 Q4	$367	Buy	+36	New	+$319	﹤0.01%	1853

Other funds holding CGEM

TFCP

Twin Focus Capital Partners Boston, Massachusetts $983M AUM 37.07% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

MassMutual Private Wealth & Trust's CGEM Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Cullinan Oncology (CGEM) position steady in Q2 2026 at 27 shares worth $492. The position accounts for ﹤0.01% of the portfolio, ranked #2273.

MassMutual Private Wealth & Trust first reported a position in CGEM in Q4 2023 and has held it in 10 quarters since. The position peaked at $628 in Q2 2024. 31 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

MassMutual Private Wealth & Trust held 27 shares of Cullinan Oncology worth $492 as of Q2 2026.
MassMutual Private Wealth & Trust left its Cullinan Oncology share count unchanged in Q2 2026.
Cullinan Oncology made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2273 holding.
MassMutual Private Wealth & Trust first reported a position in Cullinan Oncology in Q4 2023 and has held it in 10 quarters since.
MassMutual Private Wealth & Trust's Cullinan Oncology position peaked at $628 in Q2 2024.
31 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.